Mechanism of Progressive Heart Failure and Significance of Pulmonary Hypertension in Obstructive Hypertrophic Cardiomyopathy.

about

Network Analysis to Risk Stratify Patients with Exercise Intolerance.Clinical presentations of hypertrophic cardiomyopathy and implications for therapy

P2860

Q50043686-3996DF32-C237-43EE-99DF-BA6BB36AD6A8 Q58565625-5D01E75D-E6CD-413D-90A7-F357FAA92E49

P2860

Mechanism of Progressive Heart Failure and Significance of Pulmonary Hypertension in Obstructive Hypertrophic Cardiomyopathy.

Item

http://www.wikidata.org/entity/Q38843523

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Mechanism of Progressive Heart ...... e Hypertrophic Cardiomyopathy.

@en

type

Item

label

Mechanism of Progressive Heart ...... e Hypertrophic Cardiomyopathy.

@en

prefLabel

Mechanism of Progressive Heart ...... e Hypertrophic Cardiomyopathy.

@en

P1476

Mechanism of Progressive Heart ...... ve Hypertrophic Cardiomyopathy

@en

P2093

Alexander R Opotowsky

http://www.w3.org/2001/XMLSchema#string

Barry J Maron

http://www.w3.org/2001/XMLSchema#string

Bradley A Maron

http://www.w3.org/2001/XMLSchema#string

Ethan J Rowin

http://www.w3.org/2001/XMLSchema#string

Ioana R Preston

http://www.w3.org/2001/XMLSchema#string

Martin S Maron

http://www.w3.org/2001/XMLSchema#string

Michele Covella

http://www.w3.org/2001/XMLSchema#string

Nicholas S Hill

http://www.w3.org/2001/XMLSchema#string

P2860

Hemodynamics should be the primary approach to diagnosing, following, and managing pulmonary arterial hypertension

Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.

Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy.

Accuracy of noninvasively determined pulmonary artery systolic pressure

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):

Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.

Diagnosis and treatment of secondary (non-category 1) pulmonary hypertension.

Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy.

Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.

Surgical myectomy improves pulmonary hypertension in obstructive hypertrophic cardiomyopathy.

P304

e003689

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCHEARTFAILURE.116.003689

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alberto Milan

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28396501

http://www.w3.org/2001/XMLSchema#string

P932

5390526

http://www.w3.org/2001/XMLSchema#string

Mechanism of Progressive Heart Failure and Significance of Pulmonary Hypertension in Obstructive Hypertrophic Cardiomyopathy.

about

P2860

P2860

Mechanism of Progressive Heart Failure and Significance of Pulmonary Hypertension in Obstructive Hypertrophic Cardiomyopathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932